Lucet LLC

Glycadia Pharmaceuticals, located in Philadelphia, PA, is a clinical-stage biopharmaceutical company focused on developing therapeutics aimed at preventing and treating vascular complications associated with diabetes. With a dedicated executive team and a strong emphasis on scientific research, the company is at the forefront of addressing critical health challenges related to diabetic conditions. The Board of Directors features experienced leaders from various fields, including investment, healthcare, and consulting, enhancing Glycadia's strategic direction and innovation potential. Notable members include internationally-recognized endocrinologist Dr. Arthur H. Rubenstein and financial consultant Patrick M. O'Keefe, both of whom contribute significant expertise to the organization. Generated from the website